JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB119216

Bradford Reagent

Be the first to review this product! Submit a review

|

(43 Publications)

Bradford Reagent (ab119216) is a quick, ready-to-use colorimetric method for total protein quantification.

- Improved protein dye formulation for protein quantification, offering higher tolerance to detergent (up to 1%)
- Reduced protein-to-protein variation compared to traditional Bradford assays
- Used to make standard curves to quantify both low protein range (1 µg/mL – 25 µg/mL) or high protein range (0.1 mg/mL – 1.5 mg/mL)
- Proven performance: cited in over 40 publications
4 Images
Functional Studies - Bradford Reagent (AB119216)
  • FuncS

Unknown

Functional Studies - Bradford Reagent (AB119216)
Functional Studies - Bradford Reagent (AB119216)
  • FuncS

Unknown

Functional Studies - Bradford Reagent (AB119216)
Functional Studies - Bradford Reagent (AB119216)
  • FuncS

Unknown

Functional Studies - Bradford Reagent (AB119216)
Functional Studies - Bradford Reagent (AB119216)
  • FuncS

Unknown

Functional Studies - Bradford Reagent (AB119216)

Key facts

Form

Liquid

form

Storage buffer

Constituents: 14% Phosphoric acid, 3% Ethanol, 2.3% α-Cyclodextrin hydrate, 0.23% gamma-Cyclodextrin, 0.005% Brilliant Blue G

storage-buffer

Product details

This product is manufactured by Expedeon, an Abcam company, and was previously called Bradford Ultra - 500 ml. BFU05L is the same as the 500 ml size.

Bradford Reagent ab119216 offers an improved formulation over classical Bradford: it has higher tolerance of detergent contamination of the protein samples.

This Bradford Reagent shows excellent linearity for a defined range of protein concentrations and shows significantly less protein-to-protein variation than is observed with other Bradford-type Coomassie formulations.

When Coomassie dye binds protein in an acidic medium, an immediate shift in absorption maximum occurs from 465 nm to 595 nm with a concomitant color change from brown to blue. Protein concentrations are estimated by reference to the absorbance obtained for a series of standard protein dilutions, which are assayed alongside samples with unknown protein concentrations.

Manufactured under patent numbers: US 12/226,797 ; SG 201103010-3 ; SG 200807953-5 ; JP 2009-507182 ; IN 5722/CHENP/2008 ; GB 0608377.8 ; EP 10187154.9; EP 07733647.7 ; CN 200780021434.8 ; CA 2,649,835 ; AU 2007245443.

Support on how to determine protein concentration can be found here.

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
+4°C

Product protocols

Target data

Publications (43)

Recent publications for all applications. Explore the full list and refine your search

ACS omega 10:3535-3550 PubMed39926549

2025

Macrophage Responses to Multicore Encapsulated Iron Oxide Nanoparticles for Cancer Therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Sarah Kraus,Shir Arbib,Pazit Rukenstein,Irit Shoval,Raz Khandadash,Ofer Shalev

Biology of the cell 117:e2400161 PubMed39924827

2025

Direct observation of fluorescent proteins in gels: A rapid, cost-efficient, and quantitative alternative to immunoblotting.

Applications

Unspecified application

Species

Unspecified reactive species

Matthieu Sanial,Ryan Miled,Marine Alves,Sandra Claret,Nicolas Joly,Véronique Proux-Gillardeaux,Anne Plessis,Sébastien Léon

Journal of cellular and molecular medicine 28:e18586 PubMed39121240

2024

Isoliquiritigenin diminishes invasiveness of human nasopharyngeal carcinoma cells associating with inhibition of MMP-2 expression and STAT3 signalling.

Applications

Unspecified application

Species

Unspecified reactive species

Yen-Ting Lu,Chung-Han Hsin,Shao-Hsuan Kao,Yu-Ting Ho,Fang-Ling Yeh,Shun-Fa Yang,Chiao-Wen Lin

British journal of pharmacology 181:4279-4293 PubMed38982588

2024

A vitamin D-based strategy overcomes chemoresistance in prostate cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Kateryna Len-Tayon,Claire Beraud,Clara Fauveau,Anna Y Belorusova,Yassmine Chebaro,Antonio Mouriño,Thierry Massfelder,Anne Chauchereau,Daniel Metzger,Natacha Rochel,Gilles Laverny

Journal of translational medicine 21:276 PubMed37088830

2023

The activation of mTOR signalling modulates DNA methylation by enhancing DNMT1 translation in hepatocellular carcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Mengke Chen,Yi Fang,Meinong Liang,Ning Zhang,Xinyue Zhang,Lixia Xu,Xuxin Ren,Qingfeng Zhang,Yufeng Zhou,Sui Peng,Jun Yu,Judeng Zeng,Xiaoxing Li

EMBO molecular medicine 15:e17209 PubMed37070472

2023

Hypoxia-inducible factor 1A inhibition overcomes castration resistance of prostate tumors.

Applications

Unspecified application

Species

Unspecified reactive species

Julie Terzic,Mohamed A Abu El Maaty,Régis Lutzing,Alexandre Vincent,Rana El Bizri,Matthieu Jung,Céline Keime,Daniel Metzger

Toxics 11: PubMed36668787

2023

Can Maternal Exposure to Air Pollution Affect Post-Natal Liver Development?

Applications

Unspecified application

Species

Unspecified reactive species

Yong Song,Ling Chen,Ellen Bennett,Amanda J Wheeler,Katherine Southam,Seiha Yen,Fay Johnston,Graeme R Zosky

Cell & bioscience 12:143 PubMed36056448

2022

Induced hepatic stem cells maintain self-renewal through the high expression of Myc coregulated by TET1 and CTCF.

Applications

Unspecified application

Species

Unspecified reactive species

Chen Wang,Xinlu Yu,Sai Ding,Yang Liu,Hongxia Zhang,Jingbo Fu,Bing Yu,Haiying Zhu

Science advances 8:eabo2295 PubMed35867798

2022

Hypoxia-mediated stabilization of HIF1A in prostatic intraepithelial neoplasia promotes cell plasticity and malignant progression.

Applications

Unspecified application

Species

Unspecified reactive species

Mohamed A Abu El Maaty,Julie Terzic,Céline Keime,Daniela Rovito,Régis Lutzing,Darya Yanushko,Maxime Parisotto,Elise Grelet,Izzie Jacques Namer,Véronique Lindner,Gilles Laverny,Daniel Metzger

Journal of neuroinflammation 19:182 PubMed35831910

2022

Complement activation contributes to subretinal fibrosis through the induction of epithelial-to-mesenchymal transition (EMT) in retinal pigment epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

María Llorián-Salvador,Eimear M Byrne,Manon Szczepan,Karis Little,Mei Chen,Heping Xu
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com